Jeffrey S. Kiel, Ph.D.

With over 50 years of pharmaceutical development and regulatory affairs experience, Jeffrey Kiel guides Kiel Laboratories’ strategic development as founder and CEO. Additional companies Jeffrey has founded include codaDOSE, Lazirix, Gerzirix, and Southfield Classics, and he previously held roles at Bausch & Lomb and Applied Analytical Industries. He earned his Ph.D. from the University of South Carolina, studying theoretical and applied high-performance liquid chromatography, therapeutic drug monitoring, genetic control of drug metabolism, chemometrics, and experimental design.

Back to Team